Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2022

Net Loss Per Share

Schedule of reconciliation of net loss

	For the Year Ended
	December 31,
	2022		2021
Net loss	$	(43,862,197)	$	(35,400,807)
Net loss - Non-controlling interest		(427,491)		(329,339)
Net loss attributable to NightHawk	$	(43,434,706)	$	(35,071,468)
Weighted-average common shares outstanding, basic and diluted		25,606,326		24,913,942
Net loss per share, basic and diluted - continuing operations	$	(1.60)	$	(1.41)
Net loss per share, basic and diluted - discontinued operations		(0.10)		—
Net loss per common share attributable to NightHawk Biosciences, Inc., basic and diluted	$	(1.70)	$	(1.41)

Schedule of potentially dilutive securities

	2022	2021
Outstanding stock options	7,036,874	2,954,315
Restricted stock subject to forfeiture and restricted stock units	34,001	370,170
Outstanding common stock warrants	747,383	747,383